US Stock Market Move | Johnson & Johnson's (JNJ.US) sales forecast for the 2025 fiscal year fell short of Wall Street estimates, causing a nearly 4% drop in the stock price.

On Wednesday, Johnson & Johnson (JNJ.US) opened down by nearly 4%, marking its biggest drop since July 2023, and is currently trading at 142.53 US dollars. In terms of news, Johnson & Johnson reported fourth-quarter sales of $22.52 billion, a 5.3% increase from the previous year, compared to market estimates of $22.43 billion. Johnson & Johnson's adjusted earnings per share for the fourth quarter were $2.04, down from $2.29 in the same period last year, and below the estimated $1.99. The company expects sales for the fiscal year 2025 to grow between 0.5% and 1.5%, with total sales between $89.2 billion and $90 billion. According to FactSet data, this is lower than analysts' current forecast of $90.98 billion. The company stated that without the impact of acquisitions, divestitures, or foreign exchange, sales would be higher.